Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1995 1
1998 1
2000 1
2001 1
2002 1
2003 1
2004 1
2005 2
2007 3
2008 2
2010 1
2012 1
2013 1
2014 3
2015 6
2016 3
2017 2
2018 4
2019 3
2020 3
2021 6
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
Resolution of acute intestinal graft-versus-host disease.
Thiagarajan S, Neurath MF, Hildner K. Thiagarajan S, et al. Semin Immunopathol. 2019 Nov;41(6):655-664. doi: 10.1007/s00281-019-00769-w. Epub 2019 Oct 31. Semin Immunopathol. 2019. PMID: 31673757 Review.
Especially in the presence of intestinal manifestations of GvHD, the risk that the disease takes a life-threatening, potentially fatal course is significantly increased. In the light of a rapid gain of knowledge in respect to decode innate and adaptive immunity related mec …
Especially in the presence of intestinal manifestations of GvHD, the risk that the disease takes a life-threatening, potentially fatal co
Innate lymphoid cells in graft-versus-host disease.
Konya V, Mjösberg J. Konya V, et al. Am J Transplant. 2015 Nov;15(11):2795-801. doi: 10.1111/ajt.13394. Epub 2015 Jul 30. Am J Transplant. 2015. PMID: 26228632 Free PMC article. Review.
Novel T cell/organoid culture system allows ex vivo modeling of intestinal graft-versus-host disease.
Matthe DM, Dinkel M, Schmid B, Vogler T, Neurath MF, Poeck H, Neufert C, Büttner-Herold M, Hildner K. Matthe DM, et al. Front Immunol. 2023 Aug 29;14:1253514. doi: 10.3389/fimmu.2023.1253514. eCollection 2023. Front Immunol. 2023. PMID: 37705975 Free PMC article.
Acute graft-versus-host disease (GvHD) remains the biggest clinical challenge and prognosis-determining complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT). ...In support of previous studies, we found that the intestinal intra-epithelial lymph …
Acute graft-versus-host disease (GvHD) remains the biggest clinical challenge and prognosis-determining complication after allogeneic …
Steroid-Refractory Gut Graft-Versus-Host Disease: What We Have Learned From Basic Immunology and Experimental Mouse Model.
Song Q, Nasri U, Zeng D. Song Q, et al. Front Immunol. 2022 Feb 18;13:844271. doi: 10.3389/fimmu.2022.844271. eCollection 2022. Front Immunol. 2022. PMID: 35251043 Free PMC article. Review.
While systemic glucocorticoids (GCs) comprise the first-line treatment option, the response rate for GCs varies from 30% to 50%. The prognosis for patients with steroid-refractory acute Gut-GVHD (SR-Gut-aGVHD) remains dismal. ...
While systemic glucocorticoids (GCs) comprise the first-line treatment option, the response rate for GCs varies from 30% to 50%. The prog
Targeting Integrin α4β7 in Steroid-Refractory Intestinal Graft-versus-Host Disease.
Fløisand Y, Lundin KEA, Lazarevic V, Kristiansen JD, Osnes LTN, Tjønnfjord GE, Reims HM, Gedde-Dahl T. Fløisand Y, et al. Biol Blood Marrow Transplant. 2017 Jan;23(1):172-175. doi: 10.1016/j.bbmt.2016.10.009. Epub 2016 Oct 21. Biol Blood Marrow Transplant. 2017. PMID: 27777142 Free article.
Steroid refractory acute graft-versus-host-disease of the gut is a serious complication associated with high mortality after allogeneic stem cell transplantation. Treatment options are limited and not predictably effective. We describe the treatment of steroid-refractory a …
Steroid refractory acute graft-versus-host-disease of the gut is a serious complication associated with high mortality after allogeneic stem …
Endoscopic evaluation of acute intestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation.
Altun R, Gökmen A, Tek İ, Soydan E, Kurt Yüksel M. Altun R, et al. Turk J Gastroenterol. 2016 Jul;27(4):312-6. doi: 10.5152/tjg.2016.15353. Turk J Gastroenterol. 2016. PMID: 27458845 Free article.
Upper endoscopic findings had a sensitivity of 64.7%, a specificity of 50%, a positive predictive value of 91.6% and a negative predictive value of 14.2%. ...
Upper endoscopic findings had a sensitivity of 64.7%, a specificity of 50%, a positive predictive value of 91.6% and a negative pr
BATF-dependent IL-7RhiGM-CSF+ T cells control intestinal graft-versus-host disease.
Ullrich E, Abendroth B, Rothamer J, Huber C, Büttner-Herold M, Buchele V, Vogler T, Longerich T, Zundler S, Völkl S, Beilhack A, Rose-John S, Wirtz S, Weber GF, Ghimire S, Kreutz M, Holler E, Mackensen A, Neurath MF, Hildner K. Ullrich E, et al. J Clin Invest. 2018 Mar 1;128(3):916-930. doi: 10.1172/JCI89242. Epub 2018 Jan 29. J Clin Invest. 2018. PMID: 29376889 Free PMC article.
GVHD often affects the intestine and is associated with a poor prognosis. Although frequently detectable, proinflammatory mechanisms exerted by intestinal tissue-infiltrating Th cell subsets remain to be fully elucidated. ...
GVHD often affects the intestine and is associated with a poor prognosis. Although frequently detectable, proinflammatory mechanisms …
Long-Term Follow-Up After the Application of Mesenchymal Stromal Cells in Children and Adolescents with Steroid-Refractory Graft-Versus-Host Disease.
Döring M, Cabanillas Stanchi KM, Lenglinger K, Treuner C, Gieseke F, Erbacher A, Mezger M, Vaegler M, Schlegel PG, Greil J, Bettoni da Cunha Riehm C, Faul C, Schumm M, Lang P, Handgretinger R, Müller I. Döring M, et al. Stem Cells Dev. 2021 Mar;30(5):234-246. doi: 10.1089/scd.2020.0191. Epub 2021 Feb 19. Stem Cells Dev. 2021. PMID: 33446053
45 results